Mechanisms of action of fluvoxamine for COVID-19: a historical review
Yaeko Hashimoto, Takuji Suzuki, Kenji Hashimoto
Topics & Concepts
FluvoxamineDrug repositioningAntidepressantMedicineCoronavirusPandemicSerotonin syndromeSchizophrenia (object-oriented programming)PsychiatryCoronavirus disease 2019 (COVID-19)PsychologyPharmacologyDrugDiseaseSerotoninInternal medicineFluoxetineReceptorAnxietyInfectious disease (medical specialty)SerotonergicPharmacological Receptor Mechanisms and EffectsTryptophan and brain disordersAdenosine and Purinergic Signaling